Assessing laser settings in prostate surgery
Laser Outcomes Associated With HoLEP Procedures
NA · Northwestern University · NCT06531473
This study is testing if using different laser settings during prostate surgery can make the procedure quicker and improve recovery without causing problems afterward.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | Male |
| Sponsor | Northwestern University (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06531473 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of different laser frequency and wattage settings during holmium laser enucleation of the prostate (HoLEP) procedures. The researchers aim to determine if higher laser settings can significantly reduce procedural time without negative postoperative outcomes, while also exploring if lower settings can decrease irritative voiding symptoms post-surgery. The study is conducted at a high-volume practice where conventional settings are currently used, but optimal settings have yet to be established in the literature.
Who should consider this trial
Good fit: Ideal candidates are males aged 18-89 experiencing bothersome lower urinary tract symptoms due to enlarged prostates.
Not a fit: Patients with prostate measurements over 200g or those lacking decisional capacity may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced recovery times for patients undergoing prostate surgery.
How similar studies have performed: While there is limited literature on optimal laser settings for HoLEP, the study's approach is novel and aims to fill a significant gap in current knowledge.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males 18-89 who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms, that are typically caused by enlarged prostates Exclusion Criteria: * Prostates measurements over 200g * Patients who lack decisional capacity * Patients who are non-english speakers
Where this trial is running
Chicago, Illinois
- Northwestern Medicine — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Principal investigator: Amy Krambeck, MD — Northwestern University
- Study coordinator: Allaa Fadl-Alla, BS
- Email: allaa.fadlalla@northwestern.edu
- Phone: 312-724-3840
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Urologic Diseases, Prostate Obstruction